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Abstract— Coronary Computed Tomography Angiography 
(CCTA) evaluation of chest-pain patients in an Emergency 
Department (ED) is considered appropriate. While a “negative” 
CCTA interpretation supports direct patient discharge from an 
ED, labor-intensive analyses are required, with accuracy in 
jeopardy from distractions. We describe the development of an 
Artificial Intelligence (AI) algorithm and workflow for assisting 
interpreting physicians in CCTA screening for absence of 
coronary atherosclerosis. 
The two-phase approach consisted of: (1) Phase 1 - focused on 
development and preliminary Testing of an algorithm for vessel-
centerline extraction classification in a balanced study population 
(n = 500 with 50% disease prevalence) derived by retrospective 
random case selection; and (2) Phase 2 - concerned with 
simulated-clinical Trialing of developed algorithm on a per-case 
basis in a more “real-world” study population (n = 100 with 28% 
disease prevalence) from an ED chest-pain series. This allowed 
pre-deployment evaluation of the AI-based CCTA screening 
application which provides vessel-by-vessel graphic display of 
algorithm inference results integrated into a clinically capable 
viewer. Algorithm performance evaluation used Area Under the 
Receiver-Operating-Characteristic Curve (AUC-ROC); 
confusion matrices reflected ground-truth vs AI determinations. 
The vessel-based algorithm demonstrated strong performance 
with AUC-ROC = 0.96. In both Phase 1 and Phase 2, independent 
of disease prevalence differences, negative predictive values at 
the case level were very high at 95%. The rate of completion of 
the algorithm workflow process (96% with inference results in 
55-80 seconds) in Phase 2 depended on adequate image quality. 
There is potential for this AI application to assist in CCTA 
interpretation to help extricate atherosclerosis from chest-pain 
presentations. 
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I. BACKGROUND 
EW-ONSET chest pain remains a predominant clinical 
presentation to an Emergency Department (ED), and it 
can lead to significant concurrent costs from testing and/or 
anxiety, as well as future financial and/or time expenses 
following initially abnormal findings1,2; this burden persists 
despite Acute Coronary Syndrome (ACS) being a relatively 
infrequent final diagnosis (i.e., in only 17% of ED chest-pain 
cases3). However, due to the clinical or medical-legal 
consequences of failing to recognize ACS (i.e., in up to 4.4% 
of ACS cases3), ED chest-pain patients continue to be 
frequently hospitalized even when at little risk (e.g., with low-
to-intermediate pretest probability) of “obstructive” Coronary 
Artery Disease (CAD) (i.e., > 50% luminal diameter 
stenosis)2,4. This has fostered opportunity for alternative 
approaches to chest-pain evaluation, such as Coronary 
Computed Tomography Angiography (CCTA).  
Validated by its high Sensitivity for atherosclerosis 
detection, as well as its high Negative Predictive Value (NPV) 
and Specificity supporting disease exclusion, CCTA has 
become a well-established option for CAD evaluation in 
symptomatic ED patients1,2,4,5. Such use of CCTA in chest-
pain patients to effectively eliminate CAD as the cause of 
symptoms is now endorsed by professional appropriateness 
guidelines6, and it is considered especially suitable in the 
clinical setting of low-to-intermediate CAD probability as is 
found in most (i.e., over 80%7) ED presentations for suspected 
coronary-related chest pain6. Moreover, direct patient 
discharge from the ED to home based on a “negative” CCTA 
examination (often defined by absence of obstructive disease 
5) is supported by its: 1. noninvasiveness and patient 
acceptability; 2. safety and positive outcome projection (e.g., 
absent cardiac deaths, stable-to-decreased Major Adverse 
Cardiac Event (MACE) occurrence, and stable-to-decreased 
repeat visits or admissions following ED discharge); and 3. 
generic cost-savings (funds and time) to healthcare systems 
(e.g., shortened and less costly initial visits; reduced post-visit 
Artificial Intelligence to Assist in Exclusion of  
Coronary Atherosclerosis during CCTA Evaluation of 
Chest-Pain in the Emergency Department:  
Preparing an Application for Real-World Use 
Richard D. White, Barbaros S. Erdal, Mutlu Demirer, Vikash Gupta, Matthew T. Bigelow, 
Engin Dikici, Sema Candemir, Mauricio S. Galizia, Jessica L. Carpenter, 
Thomas P. O’Donnell, Abdul H. Halabi, Luciano M. Prevedello 
N 
expenses)1,2,4,8–11.  
However, for the full clinical benefit of this application to 
be realized, the complete exclusion of any coronary 
atherosclerosis, not only obstructive CAD, within the entire 
coronary artery tree per chest-pain patient is essential because 
the presence of even mild degrees of atherosclerotic plaque on 
CCTA is known to predispose to ACS12,13. In addition, if 
coronary atherosclerosis is detected on CCTA, and 
quantitation or display of atherosclerotic plaque burden is 
desired for treatment planning or prognostication14, accurate 
delineation of the coincident disease-free arteries, branches, or 
segments becomes a prerequisite. 
Unfortunately, the widespread utilization of this CCTA 
option in the ED setting is highly restricted by the non-
uniform availability of skilled interpreting physicians to 
support uninterrupted diagnostic activities across multiple 
sites10. In addition, growing pressure from referring clinicians 
for rapid turn-around of definitive imaging results, in order to 
expedite ED-patient throughput15, creates increasing 
challenges for CCTA interpreters. With rising demands on 
medical professionals related to more-and-more stressful 
healthcare delivery environments and communication 
complexities, frequent disturbances of physician workflow and 
concentration during a CCTA interpretation are growing 
prospects for professional mistakes16,17. This could potentially 
result in a falsely negative analysis, and ultimately to an 
unwanted early and dangerous discharge of a chest-pain 
patient from an ED due to undetected coronary 
atherosclerosis3. The application of Artificial Intelligence (AI) 
in medical imaging has the potential to both enhance yield and 
reduce human error in diagnostic assessments through the 
assistance it provides to interpreting physicians18,19. 
In recent years, AI-based approaches have been used for the 
direct detection and characterization of known coronary 
atherosclerosis on CCTA20–23. On the other hand, to our 
knowledge, there has been no prior application of AI to the 
direct exclusion of atherosclerosis on CCTA for the 
aforementioned reasons, especially in the ED setting. 
In this study, a two-phase approach was used to develop, 
assess, and prepare an AI algorithm for a “real-world” 
deployment aimed at prospectively assisting an interpreting 
physician in accurate and prompt exclusion of coronary 
atherosclerosis on CCTA in ED chest-pain patients. This 
preparation includes capabilities for concurrent return of 
inference results to the interpreter graphically within a clinical 
viewer, on a vessel-by-vessel basis, for adjudication. 
II. MATERIALS AND METHODS 
Following a brief description of the: (1) basics of CCTA 
imaging methodology used, (2) coronary artery image-
processing performed, and (3) AI resources employed, this 
section describes the two phases leading to the creation, 
assessment, and pre-deployment of an AI algorithm to assist 
the interpreting physician in the exclusion of coronary 
atherosclerosis on CCTA. Phase 1 was focused on the 
development and preliminary evaluation of the vessel-based 
algorithm grounded on a balanced (diseased vs non-diseased) 
study population derived by retrospective random selection of 
CCTA cases and supported by Data Augmentation (DA). 
Phase 2 was concerned with the simulated-clinical Trialing of 
the developed vessel extraction-based algorithm in a more 
“real-world” study population comprised of a recent series of 
consecutive ED cases with chest pain evaluated using CCTA. 
It allowed a pre-deployment evaluation of the proposed case-
based application, which concurrently provides to the 
interpreter the algorithm inference results by vessel-by-vessel 
graphic display integrated into a clinically capable viewer. 
A. CCTA Imaging Methodology 
All CCTA examinations were performed using American 
College of Radiology (ACR)-accredited single-source 
(Definition AS Plus, Edge, or go.Top) or dual-source 
(Definition Flash or Force) multi-detector systems [Somatom: 
Siemens Healthineers, Forchheim, Germany], with ECG-
based referencing of image-data acquisition24. Following 
standard processes25, heart-rate control (target < 60 
beats/minute using intravenous Metoprolol < 30 milligram) 
and vasodilatation (using sublingual Nitroglycerin 0.4 
milligram) preceded injector-controlled [Stellant: Medrad, 
Indianola, PA] administration of a non-ionic/low-osmolar 
contrast agent (intravenous Iohexol-350 80 ml, followed by 
saline 50 ml, at 5-6 milliliter/second) [General Electric 
Healthcare Medical Diagnostics, Chicago, IL]. Emphasizing 
the “As Low As Reasonably Achievable” principle26, 
limitation of radiation exposures was achieved using (in 
decreasing order of preference): (1) single-beat helical, (2) 
prospectively triggered sequential, or (3) pulse-modulated 
retrospectively gated helical acquisitions24,25. 
B. Coronary Artery Image-Processing 
The stepwise CCTA image-processing methodology used 
per case included: (1) segmentation of the coronary arteries in 
the entire cardiac CT volume, and (2) use of a Graphical User 
Interface (GUI)27,28 for both manual coronary artery analysis 
and the evaluation of automatic vessel-centerline extractions 
[CT Cardio-Vascular Engine: Siemens Healthineers, 
Forchheim, Germany, combined with proprietary technology 
29], which were performed on coronary arteries or branches 
either with or without atherosclerosis30 [Appendix A]. 
C. AI Resources 
AI computational support was provided by multiple servers 
and workstations with integrated Graphics Processing Units 
(GPUs) [Quadro GV100, TITAN V (Volta), GTX 1080 Ti, 
and GTX TITAN X: Nvidia, Santa Clara, CA31]. These 
systems enable technologies (e.g., Clara Medical Imaging32), 
with distributed functionality as a node cluster for processing 
optimization (e.g., Linux-based Kubernetes v1.8 for managing 
variable-generation GPUs33). 
Phase 1: Algorithm Development and Preliminary Evaluation 
Study Population: 
With local Institutional Review Board (IRB) approval, a 
retrospective electronic-record search led to the identification 
of a standard-of-care experience (5/2013-10/2018) with CCTA 
for new-onset chest pain in non-hospitalized patients. This 
experience was reflected in clinical CCTA-examination 
reports which were generated by either: (1) 1 of 8 interpreting 
physicians with verification of American College of 
Cardiology Foundation (ACCF)/American Heart Association 
(AHA) Cardiovascular Computed Tomography Experience 
(CCTE) at Level-234, but more often by (2) 1 of 2 interpreters 
with ACCF/AHA CCTE at Level-334, as well as ACR 
Certification of Advanced Proficiency in Cardiac Computed 
Tomography (COAP)35, and validation by the Certification 
Board of Cardiovascular Computed Tomography (CBCCT)36. 
From this derived collection of de-identified patient data, 
non-consecutive CCTA reports were randomly selected until 
the predetermined targets of 500 cases (including 200 cases 
from a prior technology validation report30) and 50%-disease 
prevalence were reached; the disease prevalence in the Phase 
1 study population was deliberately inflated in order to 
minimize issues related to sample size and model Training. 
Due to their potential to confound AI algorithm production, 
this selection process purposely excluded cases with: (1) 
retained metallic materials related to prior CAD intervention 
(e.g., stents, bypass graft markers, sternal sutures); or (2) other 
internal treatment-related materials (i.e., surgical or implanted 
devices, such as prosthetic valves or pacemakers). However, 
the image characteristics of the remaining cases were 
otherwise relatively “real-world” with the inclusion of all 
image qualities (e.g., equivocal from motion-related artifact) 
and complicating coronary anatomies (e.g., anomalous 
origin/course or myocardial bridges). 
The final categorization of each selected case as: (1) 
“Diseased”, with non-obstructive (i.e., at most insignificant 
stenosis < 50% everywhere) or obstructive (stenosis > 50% 
anywhere) atherosclerotic plaque formation, or as (2) 
“Normal” (totally free of coronary atherosclerosis), required 
CCTA examination review/re-review by a Level-3 
ACCF/AHA CCTE, ACR-COAP, and CBCCT investigator 
(RDW or MSG)34–36. 
Ultimately, the desired study population (Age: range 20-
91/average 50 years old; Gender: 52% male), consisting of 
250 confirmed Diseased cases (125 non-obstructive and 125 
obstructive) and 250 confirmed Normal cases, was established 
[Table 1]. All CCTA examinations had been performed in ED-
based (91%) or ambulatory clinic-based (9%) settings; cases 
of ACS (very uncommon at our institution) were 
unintentionally unrepresented. 
TABLE I 
Phase 1 Algorithm Development and Preliminary Evaluation 
The vessel-based algorithm development (including Training, Validation and Testing) utilized Mosaic Projection Views (MPVs) of vessel-centerline extractions 
following the courses of primary coronary arteries or branches which themselves did vs did not demonstrate atherosclerosis. If atherosclerosis was present along 
the vessel extraction, its extent was manually annotated (Plaque-Annotated) as non-obstructive or obstructive plaque27. During Training, 6-fold Data 
Augmentation (DA) of Plaque-Annotated MPVs provided increased representations of atherosclerotic vessels and ultimately improved Training subset balance; a 
single MPV without DA was used in both Validation and Testing of algorithm performance. 
Case-level Testing was conducted following the restoration of each Diseased case by the addition of previously excluded MPVs. 
 
 Vessel-Based Algorithm Data Subsets 
Phase 1 Study Population (n = 500)  Training Validation Testing  
Expert  
“Ground Truth” 
Case Class 
Diseased  
(n = 250 including  
125 non-obstructive / 125 obstructive) 
150 50 50  - 
Normal  
(n = 250) 150 50 50 - 
      
 Algorithm-Development Operations 
Level of Operation  Training Validation Testing Restored-Case Testing 
Vessel 
Extraction 
(MPV display) 
Plaque-Annotated  
(n = 2,539) 2,364* 50 125 -  
Atherosclerosis-Free  
(n = 3,420)  2,304 50 1,066  - 
      
Case 
Diseased     50 # & 
Normal    50 
      
Applied to  
MPVs from  
Vessel-Centerline 
Extractions  
Resulting from 6-fold DA of 394 
Plaque-Annotated MPV 
per extraction  
* - - - 
Use of single MPV per extraction - X X - 
Inclusion of extraction MPVs of 
atherosclerosis-free branches with 
“upstream” plaque annotations  
- - - 
# (n = 538 added to 
complete Diseased-case 
image datasets) 
Inclusion of completely 
atherosclerosis-free extraction MPVs   -  -  - 
& (n = 353 added to 
complete Diseased-case 
image datasets) 
 
 
Coronary Image-Data Curation: 
Image-data curation included ground-truth annotation of the 
extent of any identified coronary artery atherosclerotic plaque 
[Appendix B]27 by the most experienced investigator (RDW) 
who has 35 years of practice in cardiovascular imaging, in 
addition to the aforementioned credentials.  
Algorithm Development: 
Establishing Classification: 
In Phase 1, the development of the algorithm for coronary 
vessel classification was initiated by the establishment of a 
3:1:1 distribution37 of randomly selected study population 
cases for Training (n = 300), Validation (n = 100), and Testing 
(n = 100); each of these subsets demonstrated a 1:1 Diseased-
to-Normal case ratio [Table 1]. 
Next, depending on the assigned subset and vessel 
centerline-extraction condition (i.e., “Plaque-Annotated” vs 
“Atherosclerosis-Free”), corresponding types of Mosaic 
Projection Views (MPVs)30 were selectively recruited from 
cases as follows to establish data partitioning for vessel-based 
algorithm Training, Validation, and Testing. For the 250 
Normal cases, the MPVs of all vessel extractions were 
included in all three phases of AI algorithm development. On 
the other hand, for the 250 Diseased cases, while MPVs of all 
Plaque-Annotated extractions were used, the following were 
excluded for algorithm development in order to avoid both 
unrecognized similarities with atherosclerotic vessels and 
further dataset imbalance favoring Normal30: (1) extraction 
MPVs of atherosclerosis-free branches with “upstream” 
plaque annotations; and (2) completely atherosclerosis-free 
extraction MPVs [Table 1]. 
In order to further promote the relative balance of diseased 
vs non-diseased for algorithm development, a DA strategy was 
used to randomly permute and augment 6-fold the 394 Plaque-
Annotated MPVs in the Training subset30, thereby creating 
2,364 (i.e., 394 x 6) unique representations of atherosclerotic 
vessels [Table 1]. Traditional DA routines (e.g., random 
rotation) were also performed38–41.  
On the other hand, DA was not performed on: (1) 
Atherosclerosis-Free MPVs of Normal cases in the Training 
subset (n = 2,304); (2) the entire Validation subset of MPVs 
(both atherosclerotic and non-atherosclerotic); and (3) the 
entire Testing subset of MPVs (both atherosclerotic and non-
atherosclerotic). In the Validation subset, only one MPV was 
randomly selected per Diseased case (n = 50 MPVs) and per 
Normal case (n = 50 MPVs), in order to maintain balance and 
avoid bias in the final algorithm selection30. In the vessel 
extraction-level Testing subset, a single MPV per Plaque-
Annotated extraction (n = 125 MPVs), as well as for each 
Atherosclerosis-Free extraction (n = 1,066 MPVs), was used 
[Table 1]. 
Testing on the case level in Phase 1 (i.e., preliminarily 
evaluating the algorithm in differentiating between cases with 
vs without coronary atherosclerosis) was performed after full 
restoration of the Diseased cases. Restoration was 
accomplished by inclusion of the aforementioned initially 
excluded MPVs (n = 538 atherosclerosis-free with “upstream” 
plaque annotations, and n = 353 completely atherosclerosis-
free), for completion of Diseased-case image-data sets [Table 
1].  
Modeling: 
A Transfer Learning (TL) strategy38–41, which has been 
previously validated30, was used to help prepare the AI model 
for CCTA classification [Appendix C]. 
Phase 2: Algorithm Trialing and Pre-Deployment Assessment 
Study Population: 
With local IRB approval, the GUI27,28 was installed on a 
standard Picture Archiving and Communication System 
(PACS) workstation supporting commercially available 
advanced image-evaluation software (syngo.via: Siemens 
Healthineers, Forchheim, Germany). This allowed Trialing of 
the developed algorithm in a fashion simulating “real-world” 
use on a recent standard-of-care series (1/2019-04/2020) of 
100 consecutive suitable patients with histories of ED-
indicated CCTA evaluation of new-onset chest pain in the 
setting of low-to-intermediate pretest CAD probability. Out of 
the total of 106 case records accessed to achieve this goal, 
only 6 cases were excluded based on: (1) inadequate image 
quality for AI inference generation although reported as 
completely free of atherosclerosis by the interpreting 
physician (n = 4, representing an algorithm workflow-
completion level of 100/104 = 96%); (2) CT scanner 
malfunction resulting in incomplete CCTA examination (n = 
1); and (3) presence of a potential AI confounder (n = 1 with 
implanted defibrillator). 
In this Phase 2 series, each clinical CCTA-examination 
underwent review/re-review by a Level-3/COAP/CBCCT 
investigator (RDW or MSG)34–36 for final categorization as: 
(1) Diseased, with non-obstructive or obstructive 
atherosclerotic plaque formation, or (2) Normal. Finally, this 
100-consective-case study population from the ED (Age: 
range 22-70/average 45 years old; Gender: 58% male), 
consisted of 28 confirmed-Diseased and 72 confirmed-Normal 
cases, reflecting a disease prevalence of 28% atherosclerotic 
cases (22 non-obstructive and 6 obstructive); there were no 
confirmed ACS cases in this series. 
Algorithm Trialing: 
During algorithm Trialing in Phase 2, the CCTA image-
data of each of the 100 study cases was initially reviewed on 
the aforementioned advanced clinical viewer (i.e., syngo.via), 
as in standard-of-care, for the identification of the cardiac 
phase with perceived optimal diagnostic quality (often end-
diastolic at 65%-75%). Once identified, the following basic 
steps occurred: (1) the optimal image-data volume was routed 
for the previously described image processing necessary for 
algorithm assessment; (2) an algorithm inference was returned 
(55-80 seconds later, depending on processing and/or network 
demands) to the GUI with a vessel-by-vessel graphic overlay 
indicating any detected atherosclerosis on the displayed 
coronary artery tree (composite 3D display of centerline-
extracted coronary vessels); and (3) interpreter adjudication 
(accept/reject) with potential CCTA revisiting on the GUI, as 
justified on indicated likelihood of coronary atherosclerosis42 
[Appendix D].  
D. Statistical Analysis 
In Phase 1, Testing of the performance of the AI algorithm 
for vessel-extraction classification (Plaque-Annotated vs 
Atherosclerosis-Free) in the 500-random case study 
population was evaluated using the Area Under the Receiver 
TABLE II 
Statistical results from Testing at vessel-extraction level 
 
Phase 1 Algorithm Performance Testing: Vessel-Extraction Level (Decision Threshold: 0.5) 
  Formula Confusion Matrix Values  Calculated Value 95% CI 
Sensitivity  107 / (107+18) 85.60% 78.20% to 91.24% 
Specificity  988 / (78+988) 92.68% 90.95% to 94.17% 
PPV  107 / (107+78) 57.84% 52.27% to 63.22% 
NPV  988 / (18+988) 98.21% 97.28% to 98.83% 
Accuracy  (107+988) / (107+78+18+988) 91.94% 90.25% to 93.42% 
(FN=False-Negative, FP=False-Positive, NPV=Negative Predictive Value, PPV=Positive Predictive Value, TN=True-Negative, and TP=True-Positive) 
 
TABLE III 
Statistical results on preliminary Testing of randomly selected cases 
 
Phase 1 Algorithm Performance Testing: Randomly Selected-Case Level   
  Formula Confusion Matrix Values  Calculated Value 95% CI 
Sensitivity  49 / (49+1) 98.00% 89.35% to 99.95% 
Specificity  20 / (30+20) 40.00% 26.41% to 54.82% 
Disease 
Prevalence  (49+1) / (49+30+1+20) 50.00% - 
PPV  49 / (49+30) 62.03% 56.48% to 67.27% 
NPV  20 / (1+20) 95.24% 73.61% to 99.31% 
Accuracy  (49+20) / (49+30+1+20) 69.00% 58.97% to 77.87% 
(FN=False-Negative, FP=False-Positive, NPV=Negative Predictive Value, PPV=Positive Predictive Value, TN=True-Negative, and TP=True-Positive) 
 
TABLE IV 
Statistical results from Trialing on consecutive cases 
Phase 2 Algorithm Performance Trialing: Consecutive-Case Level    
  Formula Confusion Matrix Values  Calculated Value 95% CI 
Sensitivity  26 / (26+2) 92.86% 76.50% to 99.12% 
Specificity  36 / (36+36) 50.00% 37.98% to 62.02% 
Disease 
Prevalence  (26+2) / (26+36+2+36) 28.00% - 
PPV  26 / (26+36) 41.94% 35.93% to 48.19% 
NPV  36 / (2+36) 94.74% 82.27% to 98.59% 
Accuracy  (26+36) / (26+36+2+36) 62.00% 51.75% to 71.52% 
(FN=False-Negative, FP=False-Positive, NPV=Negative Predictive Value, PPV=Positive Predictive Value, TN=True-Negative, and TP=True-Positive) 
 
Operating Characteristic Curve (AUC-ROC) methodology43. 
For standard analysis of Testing results (especially NPV), 
confusion matrices were used to reflect expert “ground-truth” 
determinations vs AI-algorithm predictive determinations of 
atherosclerosis presence vs absence at both the vessel-
extraction level and case level38–41. As previously mentioned, 
case-level Testing was performed after Diseased case 
restoration by addition of previously excluded: (1) extraction 
MPVs of atherosclerosis-free branches with “upstream” 
plaque annotations; and (2) completely atherosclerosis-free 
extraction MPVs. 
In Phase 2, algorithm Trialing was performed on the 100-
consecutive-case study population from the ED, using 
confusion matrices to reflect expert determinations vs 
algorithm determinations of atherosclerosis presence vs 
absence on a per-case basis. 
III. RESULTS 
 Phase 1: Algorithm Development and Preliminary Testing 
In the Phase 1 500-case study population, expert ground-
truth was established for 3,420 Atherosclerosis-Free vessel-
centerline extractions from the 250 Normal cases, as well as 
for 569 (i.e., 394 + 50 + 125) Plaque-Annotated extractions 
from the 250 Diseased cases [Table 1]. While all 3,989 (i.e., 
3,420 + 569) vessel extractions were converted to MPVs for 
Training, Validation, and Testing during algorithm 
development; only the 394 Plaque-Annotated MPVs in the 
Training subset underwent DA (creating 2,364 different 
representations of atherosclerotic arteries/branches). 
The optimized algorithm developed in Phase 1 revealed 
potentially very high performance at the vessel-extraction 
level, with an AUC-ROC of 0.96 measured [Figure 1]. When 
the Testing results were reviewed further [Table 2], the 
confusion matrix statistics confirmed the potential strength of 
the algorithm for total exclusion of atherosclerosis per vessel 
extraction, with calculated high NPV of 98.21% (95%CI 
97.28% - 98.83%) and Specificity of 92.68% (95%CI 90.95% 
- 94.17%). 
Nevertheless, with the ultimate goal being to assess AI in 
screening for the absence of atherosclerosis anywhere within a 
chest-pain patient’s coronary artery system on CCTA, case-
level evaluation was the major focus. To that end, the 
developed algorithm was applied in Phase 1 to per-case 
evaluation in the Testing subset (including 50 restored 
Diseased cases and 50 Normal cases) [Table 3]. The results 
revealed a case-level NPV of 95.24% (95%CI 73.61% to 
99.31%) and Specificity of 40.00% (95%CI 26.41% to 
54.82%). There was False-Negative (FN) determination in 
only 1 case which demonstrated a single atherosclerotic 
narrowing of mild severity (25-49% stenosis) immediately 
after the origin of the vessel [Figure 2]. 
Phase 2: Algorithm Trialing and Pre-Deployment Assessment 
When the developed algorithm was applied to per-case 
Trialing in the Phase 2 study population (including 28 
Diseased cases and 72 Normal cases), the workflow 
experience was operationally successful [Figure 3] and the 
results resembled Phase 1 preliminary case-level results 
[Table 3]. NPV of 94.74% (95%CI 82.27% to 98.59%) and 
Specificity of 50.00% (95%CI 37.98% to 62.02%) were 
calculated at the case level in Phase 2. The results revealed 
FN determination in only two cases; both demonstrated single-
vessel (both Left Anterior Descending coronary artery) non-
obstructive atherosclerosis (<25% and 25-49% stenosis) 
immediately beyond branch origins [Figure 4]. Although not 
leading to case-level FN determinations, there were 5 
additional vessel extraction-level FN determinations (3 Right 
 
Fig. 1. Area Under the Receiver Operating Characteristic Curve (AUC-ROC) 
curve from Testing of vessel-based algorithm performance. 
 
 
Fig. 2. Single false-negative case-level determination during preliminary 
algorithm Testing 
  
A focal mild (24-49%) atherosclerotic stenosis [Arrows] immediately after 
the origin of the Left Circumflex coronary artery, with bifurcation of the Left 
Main Coronary Artery, is shown on the volume-rendered (Upper Left) image 
and multi-planar reconstructions (Upper Right and Lower Left). A VGG16-
based saliency map (Lower Right) superimposed on the MPVs (unique 18 x 1 
matrices of arranged 2D projections–newer version) of this case demonstrates 
a focal “hot spot” region indicating a discriminative area by the algorithm 
(corresponding to manually demarcated segment of mild atherosclerosis 
[yellow]) along projection images from the vessel extraction. However, this 
“hot spot” went under-represented due to the predicted probability for plaque 
of only 0.02, below the diagnostic threshold used (i.e., 0.5).   
Coronary Artery, including 2 main portion and 1 posterior 
descending branch; and 2 Left Circumflex coronary artery, 
including 1 main portion and 1 obtuse marginal). 
IV. DISCUSSION 
Building on a shared view that non-obstructive coronary 
artery atherosclerosis detected during CCTA evaluation of 
chest-pain should not be ignored44,45, this work was focused 
on the added diagnostic value of AI in assisting the 
interpreting physician. The importance of totally excluding 
coronary atherosclerosis aided by AI, particularly in typical 
ED chest-pain patients of low-to-intermediate pretest CAD 
probability, has implications beyond facilitating discharging to 
home, operational efficiencies, and financial benefits; failure 
to detect even mild coronary plaque formation can leave the 
patient in jeopardy of a future MACE12,13. Therefore, the 
confident confirmation of a completely normal-appearing 
CCTA to help determine minimal risk in an ED chest-pain 
patient should be considered to be an important objective 
along with the detection of CAD. 
Based on the results of this study, AI could soon play a 
significant role in assisting the interpreting physician in 
achieving this objective of coronary atherosclerosis exclusion. 
First, they indicate a very high performance of the developed 
AI algorithm at the vessel level (i.e., AUC-ROC = 0.96); the 
small number of FN determinations resulted in very high NPV 
(i.e., 98%) and high Specificity (i.e., 93%) per vessel 
extraction. Multiple prior validation studies have also 
demonstrated a strong ability of CCTA to exclude 
atherosclerosis per vessel4,5,46,47, but this has necessitated 
labor-intensive manual analysis which may be difficult to 
support, for the aforementioned reasons, within an ED 
environment. 
More pertinent to the practical goal of totally excluding 
coronary atherosclerosis per chest-pain patient for their 
clinical disposition and treatment planning in the ED, our AI 
algorithm demonstrated very high NPV (95%) in both the 
Phase 1 (disease prevalence of 50%) and Phase 2 (disease 
prevalence of 28%) study populations, thereby indicating that 
the post-test probability of an ED chest-pain patient having no 
coronary atherosclerosis, given a completely atherosclerosis-
free AI-evaluated CCTA result, approaches absolute, with low 
likelihood of a FN determination48. On the other hand, our 
previously described high Specificity per-vessel extraction 
was not observed in either case population (40% and 50%, 
respectively), reflecting the equivocal ability of our algorithm 
to alone correctly designate an ED chest-pain patient without 
coronary atherosclerosis as being completely atherosclerosis-
free, with significant potential for False Positive 
determinations warranting thorough manual evaluations for 
suspected plaque formations48. Even when CCTA 
examinations are manually interpreted, decline in Specificity 
 
 
Fig. 3. Algorithm inference feedback on detected atherosclerosis. 
 
Non-obstructive atherosclerosis [Yellow Brackets] spanning the levels of the 
Left Main Coronary Artery [LMCA] to the proximal-mid Left Anterior 
Descending coronary artery [LAD] is demonstrated on multi-planar-
reconstruction and maximum-intensity-projection images from a commercial 
clinical viewer (Above). The GUI display (Below) supports comparable 
interactive-viewing capabilities, as well as a graphic overlay of inference 
results from plaque detection [Red] on the vessel-centerline extracted 
coronary tree [Gray]. Algorithm-based detection of atherosclerosis in the 
LMCA, Proximal LAD (from LMCA bifurcation to origin of first Diagonal 
branch [D1]) and mid LAD (from D1 original to origin of second Diagonal 
branch [D2]) conveys distally to the “down-stream” non-diseased distal LAD 
and D1-D3.  Without disease detected in the Left Circumflex coronary artery 
[LCx] or Right Coronary Artery [RCA], no overlays are applied to their 
vessel distributions. 
 
 
 
Fig 4. False-negative case-level determinations during algorithm Trialing  
 
False-negative determinations were observed in only 2 cases; both 
demonstrated single-vessel non-obstructive atherosclerosis of the Left 
Anterior Descending coronary artery (LAD) immediately beyond a branching 
point.  In case A (Above), curved and straight multi-planar reconstructions 
show minimal (< 25%) atherosclerotic stenosis [Red Arrows] in the LAD 
after its origin from the Left Main Coronary Artery; an adjacent very small 
Ramus Intermedius branch is noted. In case B (Below), straight and curved 
multi-planar, as well as Volume Rendered (Right), reconstructions show focal 
atherosclerosis causing mild (25-49%) stenosis [Yellow Arrows] of the mid 
LAD just beyond the origin of the first Diagonal branch. 
 
per-patient, compared to per-segment or per-vessel basis, has 
been reported4,5,46,47. 
Hence, these results do not endorse the use of our algorithm 
for autonomous AI-based CCTA interpretation; this was not 
anticipated, especially when it is recognized that expert review 
is still essential due to potential for other symptom-producing 
abnormalities, such as congenital coronary artery anomalies. 
However, they do help validate its use as a pre-view or post-
view assistant to the interpreting physician in preventing 
mistakes of diagnostic omission that might otherwise lead to 
unrecognized risks of MACE by failing to detect coronary 
atherosclerosis prior to ED discharge without plans for further 
evaluation or treatment. In addition, to that end, the results 
indicate that our algorithm workflow is robust with: (1) 
reliable performance when image quality is not poor (100 of 
104 = 96% of real-world cases without obvious confounders 
demonstrated algorithm workflow completion with inference 
feedback); (2) acceptable turnaround time (55-80 seconds) of 
graphic inference results; and (3) post-inference opportunity 
for the interpreting physician to adjudicate inference results by 
easy interactive re-review of CCTA images within the same 
clinically capable GUI. 
Limitations 
Limitations in Study Population: 
Unlike prior reports on the use of AI for 
anatomic/physiologic detection or characterization of known 
coronary artery atherosclerotic plaque20–23, this project focused 
on the AI-based exclusion any atherosclerosis. Apparent 
deficiencies in autonomous detection of atherosclerosis (per-
case positive predictive values of 42-62%) are likely related to 
both Phase 1 and Phase 2 study populations having included: 
1. relatively “real-world” examinations spanning all image 
qualities (rendering workflow incomplete in 4 Phase 2 cases 
with very poor imaging); and 2. a high prevalence of vessel 
extractions which were atherosclerosis-free or had non-
obstructive (often very mild) atherosclerosis, partially 
ameliorated in Phase 1 but left in “real world” status in Phase 
2. In order to correct for this latter issue for algorithm 
development in Phase 1, disease prevalence was purposefully 
inflated to 50% during case selection in order to minimize the 
sample-size concern; consequently, the calculated sample-size 
need (i.e., 146 cases) was reduced to a level surpassed by the 
combined Training-Validation subsets (i.e., 400 cases) and 
approximated by the Testing subset (i.e., separate 100 cases). 
Data balancing was also employed to ensure disease 
representation throughout the vessel-based algorithm 
development process30.  
Limitations in Technology: 
A variety of technique options are available for vessel-
centerline extraction, and each has relative inherent strengths 
and deficiencies49, beyond practical restrictions related to poor 
image quality, reduced intravascular enhancement, and severe 
vessel tortuosity. Technical limitations of the fully automatic 
centerline methodology applied in this study have been 
described27,30, and cumulatively these limitations may have 
adversely affected vessel extraction and ultimately algorithm 
development. 
In addition, known shortcomings with centerline 
recognition at vessel bifurcations may have contributed to the 
occurrence of missed AI-algorithm detection of focal 
atherosclerotic plaques in this study50. Nevertheless, the three 
depicted instances leading to FN cases involved failed 
detection of non-obstructive degrees of atherosclerosis, 
regarded to be “negative” in many prior studies of CCTA in 
ED chest pain-patients5. Also, planned work to support the 
continuous learning process of our AI algorithm (in contrast to 
traditional computer aided diagnosis38–41) is expected to 
improve its future performance, thereby reducing the potential 
for such FN inference results. 
 Lastly, there are impending clinical implementation issues 
related to the current algorithm workflow, including its: (1) 
requirement for manual selection of the cardiac phase with 
optimal image quality which may eventually be overcome 
with technical options (e.g., automatic phase selection51, 
optimization via motion correction52); 2. inability to 
graphically display local regions of highest probability for 
plaque detection, or provide for probability threshold 
adjustment, which may be overcome with 3D and/or neural 
network-dependent approaches in the future; and (3) ongoing 
dependencies on interfacing of commercially based (e.g., 
centerline technology) and locally developed approaches (e.g., 
MPV production), also potentially benefitting from the same 
approaches. 
V. CONCLUSION 
This report describes the methodical development of an AI 
algorithm, and supporting workflow, which appears to have 
reached a level of performance conducive to clinical 
deployment for assisting an interpreting physician in 
confirming the total absence of any coronary artery 
atherosclerosis on CCTA during a chest-pain patient 
evaluation in the ED setting. The AI application’s validated 
combination of: (1) very high NPV at the case level; (2) 
efficient return of results from algorithm inference; and (3) 
graphic overlay of inference results on the coronary artery tree 
display, with allowance for subsequent interactive review of 
CCTA images within the same “user friendly” GUI, promotes 
its readiness for clinical implementation. It also anticipates the 
expectation for support of continuous algorithm improvement, 
inherent in AI. Provision of such AI-based assistance to the 
interpreting physician in confidently discounting coronary 
atherosclerosis as the cause of chest pain in an ED chest-pain 
patient could help to avoid under-diagnosis or under-treatment 
due to human error. 
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APPENDICES 
Appendix A 
Because all vessel-centerline extractions originated at the 
transition from the aortic root to either the Left Main Coronary 
Artery or Right Coronary Artery (standard in commercial 
coronary artery image-processing systems), the sharing of an 
“up-stream” arterial segment between “down-stream” 
segments of the same primary artery or its branches is 
common. In this study, while the identification of each vessel 
extraction was based on the vessel of termination, its 
classification as “Plaque-Annotated” or “Atherosclerosis-
Free” was established by the presence or absence, 
respectively, of atherosclerosis anywhere along the vessel 
extraction, even when atherosclerosis was located only before 
the true origin of a branch [Figure A]. 
Appendix B 
The GUI-based manual annotation process involved 
regional color-coding of basic stenosis grade (i.e., non-
obstructive vs obstructive) along the vessel courses as shown 
on rotatable 3D branching arterial trees, representing the 
combined display of the multiple vessel-centerline extractions 
per case27 [Figure B1]. 
The annotated vessel extractions (i.e., Plaque-Annotated) 
were then converted to 2D Mosaic Projection View (MPV) 
displays in order to facilitate Data Augmentation (DA) of the 
size of the atherosclerotic-vessel component of Training for 
algorithm development30. DA is accomplished by re-ordering 
projections, thereby creating new MPVs per vessel used to 
augment the Training subset [Figure B2]. Through its 
improvements to both modeling and diseased vs non-diseased 
balance within the Training subset37, this DA methodology 
 
 
 
Fig A. Classification of vessel-centerline extractions  
 
Significant luminal narrowing [Arrows] of the Left Anterior Descending 
coronary artery [LAD] is demonstrated on both a volume-rendered image 
(Above, with automatically extracted centerlines indicated on Right) and 
curved multi-planar images along the vessel centerlines (Below). The “up-
stream” atherosclerotic proximal LAD dictates the classification of both the 
“down-stream” atherosclerosis-free mid-distal LAD and first Diagonal branch 
[D1] as “Plaque-Annotated”. Hence, D1 is considered a diseased vessel 
course due to the proximal LAD atherosclerosis; for it to be considered 
Atherosclerosis-Free requires all segments proximal to the branch to also be 
free of atherosclerosis. On the other hand, the Left Circumflex coronary artery 
[LCx] and its first Obtuse Marginal branch [OM1] are entirely 
Atherosclerosis-Free along their vessel extractions. [D2 = second Diagonal 
branch; RI = Ramus Intermedius branch] 
 
 
 
 
Fig B1. GUI for ground-truth annotation of coronary arteries and branches  
 
The same case as represented in Figure A helps to demonstrate the subsequent 
GUI-based image-data curation with ground-truth annotation of coronary 
artery atherosclerotic plaque extent. This process involves regional color-
coding of basic stenosis grade of the previously described significant stenosis 
[Arrow] of the proximal Left Anterior Descending coronary artery [LAD]; 
both non-obstructive (< 50% luminal narrowing [Light Pink]) and obstructive 
(> 50% luminal narrowing [Dark Pink]) portions of the plaque are shown as 
segmental coatings on the 3D branching arterial tree [D1 = first Diagonal 
branch; LCx = Left Circumflex coronary artery; RI = Ramus Intermedius 
branch] 
enhanced AI algorithm development, especially when 
combined with Transfer Learning (TL) using pre-trained 
weighting30,37–41. 
Appendix C 
Inception-V3 [https://cloud.google.com/tpu/docs/inception-
v3-advanced] served as the base convolutional neural network. 
Model weights pre-trained on ImageNet [http://www.image-
net.org/] were used for TL during algorithm Training30,38–41. 
To refine modeling for CCTA datasets, the final Inception-V3 
layer was replaced by a fully connected 1024-node layer with 
a rectified linear unit (25% dropout to avoid overfitting), 
followed by sigmoid output function for binary classification30 
[Figure C]. 
Training utilized the Keras library [https://keras.io/] with a 
TensorFlow-1.8 backend [https://www.tensorflow.org/]. Initial 
learning rate was 0.001 on a stochastic gradient descent 
optimizer (decay factor 1e-6, with momentum 0.900 and mini-
batch size 8); re-training was terminated at 120 epochs. A 
binary cross-entropy loss function was monitored during 
Training, and the resulting model was saved only if there was 
improvement in the Validation accuracy30. 
Appendix D 
For Phase 2, Clara software stack 
[https://developer.nvidia.com/clara-medical-imaging] was 
used because of its support of: (1) an interface to Digital 
Imaging and Communications in Medicine (DICOM) 
standards [www.dicomstandard.org]; (2) a durable deployment 
of Kubernetes [https://kubernetes.io/docs/tasks/manage-
gpus/scheduling-gpus/#clusters-containing-different-types-of-
nvidia-gpus]; and (3) seamless modular integration with 
existing image-visualization/analysis tools, including a PACS 
or a viewer.  
The integrated workflow for pre-deployment of the 
algorithm developed in Phase 1 included the following steps: 
(1) the interpreting physician opened the desired CCTA 
image-data in a commercial clinical viewer 
[https://www.siemens-healthineers.com/en-us/medical-
imaging-it/advanced-visualization-solutions/syngovia] in 
order to select the most diagnostically optimal cardiac phase to 
undergo evaluation by the algorithm; (2) the selected volume 
was manually forwarded to the DICOM server from where it 
was sent to the server supporting the GUI 
[https://www.mevislab.de/] for coronary artery image-
processing (including vessel-centerline extraction followed by 
production of straightened Multi-Planar Reformations 
(MPRs); (3) following conversion, straightened-MPRs were 
sent to a Clara Deploy DICOM Adapter 
[https://docs.nvidia.com/clara/deploy/ngc/DicomAdapter.html
] which monitors incoming DICOM images and initiates 
classification by the algorithm; (4) Clara Deploy platform, 
hosting a TensorRT Inference server 
[https://docs.nvidia.com/deeplearning/sdk/triton-inference-
server-guide/docs/index.html], is prompted to make 
predictions; (6) inference results are updated in the database 
 
Fig C. Modified Inception-V3 convolutional neural network used for algorithm development 
 
 
Fig B2. Mosaic Projection View (MPV) representations of disease-annotated 
vessel extractions 
 
Three MPVs (unique 9 x 2 matrices of arranged 2D projections – original 
version [30]) of coronary vessel atherosclerosis with variable stenosis are 
displayed as color maps (Right); corresponding plaques are shown on curved 
CCTA reconstructions (Left). [LAD = Left Anterior Descending, LCx = Left 
Circumflex, RCA = Right Coronary Artery]. 
[https://www.mongodb.com/], signaling readiness for 
feedback to the interpreting physician; and (7) inference 
probability values exceeding the threshold (0.5) are 
graphically displayed as overlays on the coronary artery tree 
displayed by the GUI. 
Using a continuous model integration strategy, an additional 
model can be evaluated by updating the CLARA Deploy 
server, via the backend server without workflow disruption, 
for future selection by the interpreting physician. The 
application described in Phase 2 and pre-deployed for 
simulated clinical use is illustrated below [Figure D].  
 
 
 
 
 
Fig D. Algorithm Pre-Deployment Architecture 
 
While blue components reflect a traditional Radiology workflow, orange 
components are enhancements for AI algorithm deployment with graphic 
inference feedback to the interpreting physician via the GUI 
 
